TABLE 1.

Incidence and mortality of reproductive-related cancers in women in Guangzhou 2010–2020 (per 100,000).

Year	Breast cancer				Cervical cancer				Uterine cancer				Ovarian cancer
	Incidence		Mortality		Incidence		Mortality		Incidence		Mortality		Incidence		Mortality
	Crude rate	ASIR a	Crude rate	ASMR a	Crude rate	ASIR	Crude rate	ASMR	Crude rate	ASIR	Crude rate	ASMR	Crude rate	ASIR	Crude rate	ASMR
2010	62.39	62.53	10.13	9.76	18.58	18.98	3.43	3.47	14.84	14.78	2.64	2.55	10.97	10.95	3.36	3.16
2011	64.81	64.57	12.60	12.11	18.60	18.89	3.24	3.20	16.37	16.23	3.65	3.40	10.69	10.57	3.83	3.61
2012	63.96	63.23	11.90	11.23	18.24	18.31	3.44	3.33	16.35	16.05	3.99	3.74	10.38	10.14	4.51	4.18
2013	74.60	72.23	13.13	12.12	21.45	21.31	4.19	3.97	17.41	16.82	3.65	3.35	10.35	9.97	4.43	4.03
2014	73.91	71.11	12.88	11.62	20.34	19.85	5.14	4.73	19.49	18.58	2.79	2.53	9.85	9.32	4.06	3.64
2015	68.80	65.75	14.75	13.14	17.67	17.13	4.83	4.32	18.65	17.54	3.30	2.82	10.64	10.06	4.71	4.16
2016	66.70	62.99	15.63	14.19	18.55	17.57	6.07	5.52	18.12	16.92	3.40	2.99	11.20	10.65	5.56	4.74
2017	73.38	68.47	15.67	13.70	21.99	21.24	6.43	5.89	17.97	16.73	3.41	2.95	9.98	9.37	4.88	4.24
2018	74.00	69.11	16.11	13.62	17.22	16.17	5.26	4.64	17.79	16.51	3.83	3.24	8.74	8.13	5.02	4.31
2019	73.06	67.13	14.86	12.67	16.49	15.28	5.45	4.65	18.76	17.14	4.22	3.56	10.33	9.42	5.56	4.69
2020	60.95	55.91	15.03	12.42	12.87	11.75	5.28	4.38	16.72	15.11	3.92	3.29	6.77	6.11	4.62	3.74

^a ASIR, age-standardized incidence rate of the Chinese population; ASMR, age-standardized mortality rate of the Chinese population.